Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.

Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.

Item
http://www.wikidata.org/entity/Q30300234
The role of vedolizumab in patients with moderate-to-severe Crohn's disease and ulcerative colitisThe safety of vedolizumab for the treatment of ulcerative colitis.Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative ColitisEfficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort.Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis.Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitis.Immune deficiency vs. immune excess in inflammatory bowel diseases-STAT3 as a rheo-STAT of intestinal homeostasis.Vedolizumab for the treatment of ulcerative colitis.New treatment strategies for ulcerative colitis.Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives.Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease.Vedolizumab induction therapy for inflammatory bowel disease in clinical practice--a nationwide consecutive German cohort study.Vedolizumab in IBD-Lessons From Real-world Experience; A Systematic Review and Pooled Analysis.Organising infusions: Application administration and complications.Safety and Positioning of Vedolizumab in Patients With Inflammatory Bowel Disease.Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
P2860

Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.

Item
http://www.wikidata.org/entity/Q30300234
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Vedolizumab for induction and ...... atic review and meta-analysis.
@ast
Vedolizumab for induction and ...... atic review and meta-analysis.
@en
type
label
Vedolizumab for induction and ...... atic review and meta-analysis.
@ast
Vedolizumab for induction and ...... atic review and meta-analysis.
@en
prefLabel
Vedolizumab for induction and ...... atic review and meta-analysis.
@ast
Vedolizumab for induction and ...... atic review and meta-analysis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Vedolizumab for induction and ...... atic review and meta-analysis.
@en
P2093
P2860
P304
P31
P356
10.1097/MIB.0000000000000396
P433
P478
P50
P577
P698